Coherus Oncology files prospectus supplement for $64.9M ATM stock offering

Coherus Oncology, Inc.

Aggregate offering price of up to $64,880,054 under Sales Agreement with TD Cowen.
Shares of common stock may be sold from time to time at then-prevailing market prices.
Legal opinion of Latham & Watkins on share validity filed as Exhibit 5.1.

item 8.01 item 9.01

Coherus Oncology, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-26-006307

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.